In order to reduce the incidence of catheter-related bloodstream infections (CRBSI) in home parenteral nutrition patients, the use of taurolidine was introduced in the Sophia Children’s Hospital in 2011” Hulshof et al (2016).
Abstract:
In order to reduce the incidence of catheter-related bloodstream infections (CRBSI) in home parenteral nutrition patients, the use of taurolidine was introduced in the Sophia Children’s Hospital in 2011. This introduction led to a reduction in CRBSI: 12.7/1,000 catheter days before the use of taurolidine, compared with 4.3/1,000 catheter days afterwards (n=7) (relative risk=0.36, 95%CI: 0.20-0.65 (p= 0,018)).
[ctt link=”4KOH1″ template=”1″]ReTweet if useful… Use of Taurolidine in pediatric home parenteral nutrition patients http://ctt.ec/4KOH1+ @ivteam #ivteam[/ctt]
Reference:
Hulshof, E.C., Hanff, L.M., Olieman, J., de Vette, S., Driessen, G.J., Meeussen, C. and Escher, J.C. (2016) Taurolidine In Pediatric Home Parenteral Nutrition Patients. The Pediatric Infectious Disease Journal. November 11th. [Epub ahead of print].
DOI: 10.1097/INF.0000000000001404
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]</>